pediatric-congress-2019-scientifictracks

Pediatric Congress 2019

Current Pediatric Research | ISSN: 0971-9032 | Volume 23

Page 33

July 25-26, 2019 | Amsterdam, Netherlands

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

YEARS

International Conference on

PEDIATRICS AND NEONATOLOGY

MY THEORY OF THE OXIDATIVE-DEOXIDATIVE IMBALANCE IN NEONATAL DISEASES

YanWang

American Physiological Society, USA

he aim of the present project is to obtain a better understanding of the imbalance of the oxidative-deoxi-

dative state of a special substance happen at it is original prefect balance; to accomplish the study, author

have worked on the projects of nitric oxidize biology in neonatal diseases and reactive oxygen species in lung

biology since 1996. She will present the lecture in general results and the related publishes at her first author

and investigator role for 40 articles in peer journal. The oxidative stress state means the reactive oxygen species

(ROS) and reactive nitrogen species (RNS) generation with over producing at the normal state in body; several

toxic agents can induce oxidative stress as stress, infection or paraquat and H2O2. The deoxidative defense

state have the anti-oxidative enzyme system, non-enzyme system, small molecular (GSH) or more formed, the

main system is the antioxidant enzymes as SOD, catalase, peroxidase defend oxidative stress through degra-

dation ROS/RNS to nontoxic chemical. There are neonatal diseases has pathophysiological phenomenon of

the imbalance of the oxidative-deoxidative state during disease development, as neonatal respiratory distress

syndrome, immunity inflammation reaction or cardiovascular function disorder. Acute lung injury is in the cen-

tral for the imbalance state during neonatal disease development. She has studied the imbalance of the oxida-

tive-deoxidative state defend diseases development for twenty years. In molecular/cell study, the procedure

death signalling can control by oxidative stress, in basic research, deoxidative interruption can deduce injury.

The medicine with anti-oxidative drug has used to treat neonatal diseases as SOD and GSH application. Neona-

tal diseases are the group diseases at the starting term of one person’s life, treating the diseases in well recovery

might affect the future of the new born baby. She has been in adventure to find new therapy as gene therapy

to decrease and cure the neonatal diseases in mission.

Yan Wang, Curr Pediatr Res 2019, Volume 23

YanWang is a Doctor and Scientist in Medicine; she has completed her PhD in Respiratory and Emergency Medicine from Fudan Uni-

versity Medical College in 1998. She has completed her Postdoctoral study from University of Miami and University of Pennsylvania

in the United States of America since 2000. She has worked at the Imperial College in London in 2014. Currently she is an attending

Doctor, Professor, Director and Academic Committee Member at hospitals, medical organizations and journal presses with posted

in the United States of America, United Kingdom and China. She has published about 100 first-authored articles on peer-reviewed

journals and conference abstracts with over ten books in the United States and the United Kingdom. She has been serving as an

Editorial Board Member of

ECronicon Cardiology and Pulmonary and Respiratory Medicine Journal in United Kingdom and Journal of

Pediatrica & Neonatal Care and Critical Care Journal

in the United States. She has presented her observations at national or interna-

tional scientific conferences with lecture, speeches and news release. Her current program is writing book, make lecture and take

committee responsibility in medicine.

BIOGRAPHY